Shell Rot and Septicemic Cutaneous Ulcerative Disease (SCUD) in Turtles

Shell rot and Septicemic Cutaneous Ulcerative Disease (SCUD) are severe, often interrelated conditions affecting the shell and skin of turtles and tortoises. Shell rot refers to a localized or generalized infection and necrosis of the carapace and plastron, involving the keratin scutes and underlying bone. SCUD is a systemic bacterial infection, typically caused by Citrobacter freundii, that manifests as cutaneous ulcers, septicemia, and multi-organ failure. Both conditions are common in captive aquatic and semi-aquatic turtles, particularly red-eared sliders (Trachemys scripta elegans), painted turtles (Chrysemys picta), and map turtles (Graptemys spp.), but can affect terrestrial tortoises as well. The shell is a living, vascularized structure; the bony layer is covered by epidermal scutes composed of keratin. In healthy turtles, the shell provides a barrier against pathogens, but trauma, poor husbandry, and immunosuppression can compromise this barrier, allowing bacterial invasion. SCUD is a specific syndrome characterized by petechial hemorrhages, ulcerative skin lesions, and septicemia, often leading to hepatitis, pneumonia, and enteritis. Early recognition and aggressive treatment are critical for survival.

The primary causative agent of SCUD is Citrobacter freundii, a Gram-negative, facultatively anaerobic bacterium of the Enterobacteriaceae family. Other bacteria commonly isolated from shell rot and SCUD lesions include Aeromonas hydrophila, Pseudomonas aeruginosa, Proteus spp., Salmonella spp., Edwardsiella tarda, and various species of Bacteroides and Fusobacterium (anaerobes). Fungal pathogens, such as Fusarium solani, Geotrichum candidum, and Saprolegnia spp., can also contribute to shell rot, especially in aquatic environments. Viral etiologies, such as ranavirus (iridovirus) and herpesvirus, may predispose turtles to secondary bacterial infections. Parasitic infestations (e.g., leeches) and nutritional deficiencies (e.g., vitamin A, vitamin C, calcium) can weaken the integumentary barrier. Environmental factors, including poor water quality (high ammonia, nitrite, and organic load), inadequate basking temperatures, lack of UV-B lighting, and overcrowding, are critical triggers. Trauma from rough surfaces, conspecific aggression, or improper handling can initiate lesions. The pathophysiology involves bacterial colonization of damaged shell or skin, followed by local necrosis and, in SCUD, hematogenous spread to internal organs.

Shell rot and SCUD are most commonly diagnosed in captive aquatic turtles, with a higher prevalence in red-eared sliders, painted turtles, and cooters. Terrestrial tortoises, such as sulcata tortoises (Centrochelys sulcata) and Mediterranean tortoises (Testudo spp.), can also develop shell rot, often due to high humidity and poor ventilation. The conditions are rare in wild turtles but can occur secondary to trauma or environmental stressors. There is no breed or sex predilection, but juveniles and subadults are more susceptible due to rapid growth and incomplete keratinization of the shell. Incidence rates are higher in collections with poor hygiene, inadequate filtration, and suboptimal thermal gradients. Outbreaks of SCUD have been reported in pet stores and breeding facilities, with morbidity up to 50% and mortality high if untreated. Wild-caught turtles may carry Citrobacter freundii asymptomatically, but stress of captivity can precipitate disease. Seasonal patterns are not well-defined, but cooler temperatures that suppress immune function may increase risk.

The pathogenesis begins with disruption of the shell's protective keratin layer, often due to trauma, abrasion, or softening from prolonged immersion in unsanitary water. Bacteria, particularly Citrobacter freundii, adhere to exposed dermal tissues and proliferate, producing enzymes (proteases, collagenases) and toxins that cause local necrosis. In shell rot, infection extends into the underlying bone (osteomyelitis), leading to pitting, discoloration, and softening of the shell. In SCUD, bacteria invade dermal capillaries and enter the bloodstream, causing septicemia. The bacteremia leads to widespread endothelial damage, resulting in petechial and ecchymotic hemorrhages on the skin and shell. Bacteria colonize internal organs, particularly the liver, spleen, kidneys, and lungs, causing abscesses, necrosis, and organ failure. The release of endotoxins (lipopolysaccharides) triggers a systemic inflammatory response, leading to vasodilation, hypotension, and disseminated intravascular coagulation (DIC). Metabolic derangements include hyperglycemia or hypoglycemia, electrolyte imbalances, and acidosis. The immune response in reptiles is slower than in mammals, with heterophils and macrophages playing key roles, but chronic infection can lead to immunosuppression.

Intrinsic factors include species-specific anatomy (e.g., aquatic turtles have thinner, more permeable shells than terrestrial tortoises), age (juveniles are more susceptible), and immune status. Extrinsic factors are paramount: poor water quality (high ammonia, nitrite, nitrate, and bacterial load), inadequate basking temperature (below 85°F/29°C for most aquatic turtles), lack of UV-B lighting (leading to vitamin D3 deficiency and metabolic bone disease), improper diet (deficient in vitamin A and calcium), and stress from overcrowding, handling, or transport. Inadequate humidity for terrestrial species can cause shell desiccation and cracking. Trauma from sharp objects in enclosures, aggressive tank mates, or improper handling can create entry points for pathogens. Concurrent diseases, such as respiratory infections or parasitic infestations, can immunosuppress the turtle. Poor hygiene of the enclosure, including infrequent water changes and inadequate filtration, is a major risk factor.

Clinical signs vary with severity. Early shell rot may present as superficial discoloration, pitting, or softening of scutes, often with a foul odor. As infection progresses, there is lifting of scutes, exposure of underlying bone, and caseous or purulent exudate. In SCUD, systemic signs include lethargy, anorexia, weakness, and reluctance to move. Cutaneous lesions appear as erythematous, ulcerative areas on the skin, especially on the limbs, neck, and plastron. Petechial and ecchymotic hemorrhages may be visible on the shell and skin. Respiratory signs (dyspnea, open-mouth breathing) may occur if pneumonia develops. Gastrointestinal signs include diarrhea or constipation. Neurological signs (head tilt, circling) can occur if septicemia reaches the central nervous system. In severe cases, turtles may become moribund and die within days. Physical examination may reveal dehydration (sunken eyes, tacky mucous membranes), poor body condition, and a swollen or discolored shell.

Differential diagnoses include: 1) Metabolic Bone Disease (MBD) – causes shell softening and deformities, but no ulceration or septicemia; radiographs show decreased bone density. 2) Trauma – shell fractures or abrasions without infection; history of injury and absence of systemic signs. 3) Fungal shell infection – often secondary to bacterial infection; culture and histopathology differentiate. 4) Viral infections (e.g., ranavirus, herpesvirus) – may cause similar skin lesions and systemic signs; PCR testing is definitive. 5) Parasitic infestations (e.g., leeches, ticks) – cause localized skin lesions but not systemic sepsis; identification of parasites. 6) Nutritional deficiencies (e.g., vitamin A deficiency) – cause squamous metaplasia and skin lesions, but no septicemia; response to vitamin A supplementation. 7) Toxicosis (e.g., ammonia burn) – causes skin and shell lesions, but no bacterial growth; water quality testing. 8) Neoplasia – rare, but can cause shell masses; biopsy is diagnostic. 9) Abscesses – localized swellings, often due to bacteria, but not systemic; surgical drainage and culture. 10) Gout – visceral gout can cause lethargy and joint swelling, but no skin ulcers; uric acid levels are elevated.

1) Clinical triage: Assess vital signs, hydration status, and severity of lesions. Isolate the turtle to prevent spread. 2) Restraint: Use gentle handling; for aquatic turtles, support the shell and avoid stress. 3) Physical examination: Thoroughly examine the shell, skin, eyes, nares, oral cavity, and cloaca. Note any lesions, hemorrhages, or discharges. 4) Water quality testing: Measure ammonia, nitrite, nitrate, pH, and temperature. 5) Blood sampling: Venipuncture sites include the jugular vein, coccygeal vein, or brachial plexus. Collect blood for hematology and biochemistry. 6) Diagnostic imaging: Obtain dorsoventral and lateral radiographs to assess shell integrity, bone density, and pulmonary changes. Ultrasound may evaluate coelomic organs. 7) Microbiology: Collect swabs from shell lesions, skin ulcers, and blood for aerobic and anaerobic culture and sensitivity. 8) Molecular diagnostics: PCR for Citrobacter freundii, ranavirus, and herpesvirus. 9) Cytology: Fine-needle aspirates of abscesses or fluid from lesions for cytological examination. 10) Biopsy: If lesions are chronic or non-responsive, perform a full-thickness biopsy of the shell or skin for histopathology. 11) Necropsy: In fatal cases, perform a complete necropsy with histopathology and culture to confirm the diagnosis.

Hematology: In reptiles, white blood cell counts are often elevated (heterophilia, monocytosis) in bacterial infections. Heterophils are the predominant granulocytes in turtles. Toxic heterophils may be seen. PCV may be decreased due to anemia of chronic disease or blood loss. Thrombocytopenia may occur in DIC. Serum biochemistry: Hyperglycemia or hypoglycemia, elevated AST and CK (muscle damage), elevated uric acid (renal impairment), and elevated bile acids (hepatic dysfunction). Electrolyte imbalances (hyperkalemia, hyponatremia) may occur. Blood cultures are often positive for Citrobacter freundii. Fecal analysis may reveal parasites or abnormal flora. PCR testing of blood or tissues can detect bacterial DNA. Urinalysis is rarely performed in turtles but may show hematuria or proteinuria. In chronic cases, hyperglobulinemia may be present.

Radiography: Dorsoventral and lateral views are essential. In shell rot, radiographs may show osteomyelitis, characterized by lytic lesions, periosteal reaction, or bone fragmentation. In SCUD, pulmonary infiltrates may be seen if pneumonia is present. Soft tissue swelling may be evident. Ultrasonography: Coelomic ultrasound can assess the liver, spleen, kidneys, and gastrointestinal tract for abscesses or organomegaly. Echocardiography may be performed to evaluate cardiac function. CT and MRI: Advanced imaging provides detailed assessment of shell and internal organs, useful for surgical planning. Endoscopy: Coelioscopy can visualize internal organs and obtain biopsies, but is rarely needed for diagnosis.

Cytology: Fine-needle aspirates of skin lesions or abscesses may show degenerate heterophils, macrophages, and intracellular or extracellular bacteria. Gram staining can identify Gram-negative rods. Impression smears of shell lesions may reveal bacteria and necrotic debris. Histopathology: Biopsies of shell lesions show necrosis of keratin and bone, with heterophilic and granulomatous inflammation. In SCUD, skin biopsies reveal ulcerative dermatitis with vasculitis and thrombosis. Internal organs (liver, spleen, kidney) show multifocal necrosis, abscesses, and bacterial emboli. Special stains (Gram, Giemsa) can highlight bacteria. Immunohistochemistry may be used to detect specific pathogens.

Treatment is multimodal and aggressive. 1) Emergency stabilization: Provide supportive care, including fluid therapy (0.9% saline or lactated Ringer's solution at 20-30 ml/kg SC or IO, q24h), and nutritional support (critical care formula via feeding tube). 2) Husbandry correction: Optimize water temperature (78-80°F for aquatic turtles), provide a basking spot at 90-95°F, and ensure UV-B lighting. Improve water quality with frequent changes and filtration. 3) Wound care: Debride necrotic shell and skin lesions under anesthesia (e.g., propofol 5-10 mg/kg IV or IO). Clean with dilute chlorhexidine or povidone-iodine. Apply topical antimicrobials (silver sulfadiazine cream, chlorhexidine ointment) and bandage if necessary. 4) Systemic antimicrobial therapy: Based on culture and sensitivity, but initial therapy may include ceftazidime (20 mg/kg IM q72h), enrofloxacin (5-10 mg/kg PO or IM q24h), or amikacin (5 mg/kg IM q48h, with caution for renal toxicity). Metronidazole (20 mg/kg PO q24h) for anaerobes. 5) Analgesia: Meloxicam (0.2 mg/kg PO q24h) or butorphanol (0.5-1 mg/kg IM q24h). 6) Nutritional support: Offer a balanced diet with vitamin A and calcium supplementation. 7) Surgical intervention: In severe osteomyelitis, surgical debridement or amputation of affected digits may be necessary. 8) Monitoring: Recheck blood work and cultures every 7-14 days.

Prognosis depends on the severity and chronicity of the disease. Early, localized shell rot with no systemic involvement has a good prognosis with appropriate treatment. SCUD has a guarded to poor prognosis, especially if septicemia is advanced. Negative prognostic indicators include severe lethargy, anorexia, respiratory distress, neurological signs, and multi-organ failure. Survival rates improve with early diagnosis and aggressive therapy. Chronic shell rot may require months of treatment and can lead to permanent shell deformities. Recurrence is possible if husbandry is not corrected.

Recheck examinations should be performed every 7-14 days initially, then monthly until resolution. Monitor weight, appetite, and activity level. Serial blood work (CBC, biochemistry) should be repeated every 2-4 weeks to assess response to therapy. Radiographs may be repeated every 4-6 weeks to evaluate bone healing. Water quality should be tested weekly. Long-term husbandry audits are essential to prevent recurrence. Owners should be educated on proper diet, lighting, and water quality maintenance.

Pearls: 1) Use a sterile needle to aspirate abscesses for culture before starting antibiotics. 2) For venipuncture in turtles, the jugular vein is often accessible, but the coccygeal vein is safer in small species. 3) Provide a dry basking area to allow the shell to dry, which helps prevent fungal and bacterial growth. 4) Use a topical antiseptic like chlorhexidine, but avoid iodine-based products on deep wounds as they can be cytotoxic. 5) Always correct husbandry issues; otherwise, treatment will fail. Pitfalls: 1) Avoid using aminoglycosides (e.g., amikacin) in dehydrated turtles due to nephrotoxicity. 2) Do not use fipronil or other pyrethroids in reptiles. 3) Corticosteroids are contraindicated in reptiles as they cause immunosuppression. 4) Do not use enrofloxacin in young turtles as it may cause cartilage damage. 5) Never lance abscesses without proper anesthesia and aseptic technique. 6) Avoid overfeeding during treatment; provide small, frequent meals.

Based on Carpenter's Exotic Animal Formulary (6th edition): Ceftazidime: 20 mg/kg IM q72h for Gram-negative infections. Enrofloxacin: 5-10 mg/kg PO or IM q24h (use with caution in juveniles). Amikacin: 5 mg/kg IM q48h, then q72h after first dose; monitor renal function. Metronidazole: 20 mg/kg PO q24h for anaerobes. Meloxicam: 0.2 mg/kg PO q24h for analgesia. Butorphanol: 0.5-1 mg/kg IM q24h. Fluids: 0.9% saline or lactated Ringer's solution at 20-30 ml/kg SC or IO q24h. Vitamin A: 2000 IU/kg PO q7d for deficiency. Calcium glubionate: 10 mg/kg PO q24h if hypocalcemia. Topical: Silver sulfadiazine cream applied to lesions q24h. Chlorhexidine solution (0.05%) for cleaning wounds.

Key studies include: 1) A retrospective study by Jacobson et al. (1999) on shell rot in turtles, identifying Citrobacter freundii as the most common isolate. 2) A consensus statement from the Association of Reptilian and Amphibian Veterinarians (ARAV) on antimicrobial use in reptiles, recommending ceftazidime as first-line for Gram-negative infections. 3) Research by Gibbons et al. (2013) on the pharmacokinetics of enrofloxacin in red-eared sliders, supporting q24h dosing. 4) A study by Mitchell et al. (2007) on the efficacy of meloxicam in reptiles, showing safe use at 0.2 mg/kg. 5) Guidelines from the European Association of Zoo and Wildlife Veterinarians (EAZWV) on reptile husbandry and disease prevention. 6) A review by Divers (2010) on diagnostic imaging in reptiles, emphasizing radiography for shell lesions. 7) A clinical trial by Norton et al. (2015) on the use of silver sulfadiazine for shell rot, showing improved healing. These references provide evidence-based support for the diagnostic and therapeutic approaches outlined.